Novel combination therapy t... - Researchers

Novel combination therapy targeting rDNA transcription and Histone Deacetylation Provides Effective Treatment for Multiple Myeloma, and Synergises in Bortezomib-Resistant MM

Citation

MacLachlan, K, Cuddihy, A, Hein, N et al 2018, 'Novel combination therapy targeting rDNA transcription and Histone Deacetylation Provides Effective Treatment for Multiple Myeloma, and Synergises in Bortezomib-Resistant MM', <>, p. 1945.

Year

2018

ANU Authors

Dr Nadine Hein
Professor Ross Hannan

Field of Research

Cancer Cell Biology

Updated: 27 July 2024 / Responsible Officer: Director (Research Services Division) / Page Contact: Researchers